Influenza hemagglutinin is spring-loaded by a metastable native conformation - PubMed (original) (raw)

Influenza hemagglutinin is spring-loaded by a metastable native conformation

C M Carr et al. Proc Natl Acad Sci U S A. 1997.

Abstract

Enveloped viruses enter cells by protein-mediated membrane fusion. For influenza virus, membrane fusion is regulated by the conformational state of the hemagglutinin (HA) protein, which switches from a native (nonfusogenic) structure to a fusion-active (fusogenic) conformation when exposed to the acidic environment of the cellular endosome. Here we demonstrate that destabilization of HA at neutral pH, with either heat or the denaturant urea, triggers a conformational change that is biochemically indistinguishable from the change triggered by low pH. In each case, the conformational change is coincident with induction of membrane-fusion activity, providing strong evidence that the fusogenic structure is formed. These results indicate that the native structure of HA is trapped in a metastable state and that the fusogenic conformation is released by destabilization of native structure. This strategy may be shared by other enveloped viruses, including those that enter the cell at neutral pH, and could have implications for understanding the membrane-fusion step of HIV infection.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Model for the spring-loaded mechanism for membrane fusion (20, 21). Envelope of an influenza virus (bottom membrane) is juxtaposed to the target membrane of the cellular endosome (Top). In the native conformation (Left) an HA trimer facilitates viral attachment via the HA1 subunits (orange). In response to acidic pH (Right), the HA1 subunits dissociate, the loop regions (yellow) become helical and extend the HA2 coiled coil (green), and the fusion-peptide regions (blue) insert into the target membrane. Membrane fusion per se appears to require only the HA2 subunit (2). Figure by Jodi M. Harris (adapted from ref. 80).

Figure 5

Figure 5

Acid-induced membrane-fusion activation and the HA conformational change. (a) At 37°C, acid-induced activity is detected at pH 6.0 (solid circles), with optimal activity at pH 5.8 (solid squares) and no activity from acid-inactivated virus (open circles). (b) The conformational change detected by immunoblot analysis was induced by acid below pH 6.0, at 37°C.

Figure 6

Figure 6

Heat-induced membrane-fusion activation and the HA conformational change. (a) At pH 7.3, heat-induced activity is detected at 58°C (solid circles), with optimal activity at 60°C (solid squares) and no activity from heat-inactivated virus (open circles). (b) The conformational change detected by immunoblot analysis was induced by heat above 58°C at pH 7.3.

Figure 7

Figure 7

Denaturant-induced membrane-fusion activation and the HA conformational change. (a) At pH 7.3 and 37°C, denaturant-induced activity is detected at 3.0 M urea (solid circles), with optimal activity at 3.5 M urea (solid squares) and no activity from urea-inactivated virus (open circles). (b) The conformational change detected by immunoblot analysis was induced by urea above 3.5M at 37°C, pH 7.3.

Figure 2

Figure 2

Schematic of the protease assay for the conformational change of HA. In one monomer of the HA trimer, the HA1 polypeptide (stippled ball and string) is connected to the HA2 polypeptide by a disulfide bond. The HA2 polypeptide spans the viral membrane (Bottom) once and includes the fusion peptide region. (a) Native HA is resistant to proteolysis. (b) The conformational change: HA1 dissociates from the top of HA2, and the fusion peptide is propelled to the top of the molecule. (c) Proteolysis of the fusogenic conformation: some of HA1 and the fusion peptide of HA2 are proteolytically degraded, leaving the majority of HA2 disulfide-bonded to a fragment of HA1. As a result, both the HA1 and the HA2 polypeptides are smaller, and this difference can be detected by SDS/PAGE and immunoblot analysis.

Figure 3

Figure 3

Conditions that induce the HA conformational change. The protease assay is used to monitor the conformation of HA on virus exposed to experimental conditions (indicated above the gel lanes). (a) Viral polypeptides are separated by SDS/PAGE and detected by Coomassie blue staining of viral proteins separated under nonreducing conditions. (b) Immunoblot analysis of samples used for a with anti-HA2 antibodies reveals disulfide-bonded HA and HA fragments, separated by SDS/PAGE under nonreducing conditions. (c) Samples identical to those in a are separated by SDS/PAGE under reducing conditions and stained with Coomassie blue (lanes are as in a). (d) Immunoblot analysis of samples used for c with anti-HA2 antibodies reveals HA2 and HA2 fragments, separated by SDS/PAGE under reducing conditions (lanes are as in b). Identity of the HA2 fragment was confirmed for all four samples (pH 7.3, pH 5.0, 65°C, and 4.5 M urea) by five cycles of amino-terminal amino acid sequence analysis (see text). HA, an HA1 polypeptide disulfide bonded to an HA2 polypeptide. HA fragments, disulfide-bonded HA1 and HA2 proteolytic fragments. HA2, intact HA2 polypeptide. HA2 fragment, proteolytic fragment of HA2. M1, matrix protein. NP, nucleoprotein.

Figure 4

Figure 4

Schematic of the assay for membrane-fusion activity. Large, unilamellar vesicles (LUV) are prepared with fluorescent donor and acceptor lipids (solid and striped spheres, respectively). On excitation of the donor fluorophore (blue light, 465 nm), there is substantial resonance energy transfer to the acceptor fluorophore, so that little donor fluorescence is observed (green light, 535 nm). After membrane fusion, the lipids of the viral envelope (Flu) mix with the vesicle, separating the donor from the acceptor (LUV + Flu), leading to an increase in observed donor fluorescence.

Figure 8

Figure 8

A model for the mechanism of the HA conformational change. The metastable native state (N) undergoes an irreversible transition to the more stable fusogenic state (F). The fusogenic state induces membrane-fusion activity in the presence of target membranes and causes viral inactivation in the absence of target membranes.

Similar articles

Cited by

References

    1. Wiley D C, Skehel J J. Annu Rev Biochem. 1987;56:365–394. - PubMed
    1. Schoch C, Blumenthal R, Clague M J. FEBS Lett. 1992;311:221–225. - PubMed
    1. Stegmann T, Helenius A. In: Viral Fusion Mechanisms. Bentz J, editor. Boca Raton, FL: CRC; 1993. pp. 89–111.
    1. Hughson F M. Curr Opin Struct Biol. 1995;5:507–513. - PubMed
    1. Tatulian S A, Hinterdorfer P, Baber G, Tamm L K. EMBO J. 1995;14:5514–5523. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources